1. Home
  2. COUR vs PVLA Comparison

COUR vs PVLA Comparison

Compare COUR & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coursera Inc.

COUR

Coursera Inc.

HOLD

Current Price

$6.08

Market Cap

1.0B

Sector

Technology

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$76.70

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COUR
PVLA
Founded
2012
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
COUR
PVLA
Price
$6.08
$76.70
Analyst Decision
Buy
Strong Buy
Analyst Count
12
17
Target Price
$12.17
$145.24
AVG Volume (30 Days)
3.8M
228.3K
Earning Date
02-05-2026
11-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$739,774,000.00
N/A
Revenue This Year
$10.46
N/A
Revenue Next Year
$6.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
8.09
N/A
52 Week Low
$5.76
$12.60
52 Week High
$13.56
$114.69

Technical Indicators

Market Signals
Indicator
COUR
PVLA
Relative Strength Index (RSI) 25.02 35.75
Support Level $5.98 $82.74
Resistance Level $6.37 $106.27
Average True Range (ATR) 0.26 6.55
MACD -0.01 -2.51
Stochastic Oscillator 7.26 12.09

Price Performance

Historical Comparison
COUR
PVLA

About COUR Coursera Inc.

Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through three reporting segments: Consumer, Enterprise, and Degrees. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

Share on Social Networks: